Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologists
Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities
Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ...

Current Issue

Original article

Reducing fatigue-related symptoms in Long COVID-19: a preliminary report of a lymphatic drainage intervention

H. Heald, Adrian; Perrin, Raymond; Walther, Andreas; More

Cardiovascular Endocrinology & Metabolism. 11(2):e0261, June 2022.

Open

Naltrexone alters cardiovascular function following acute forced swimming in mice

Longoria, Candace R.; Qadiri, Quadratullah; Matthews, Evan L.; More

Cardiovascular Endocrinology & Metabolism. 11(2):e0263, June 2022.

Open

Short report

A survey of physician experience and treatment satisfaction prescribing once-weekly semaglutide injections for patients with type 2 diabetes in Canada

Qureshy, Kamran; Ross Kirk, Andreas; Lyng Wolden, Michael; More

Cardiovascular Endocrinology & Metabolism. 11(2):e0260, June 2022.

Open
SDC

Correspondence

Living with diabetes and its impact on mental health: results of an online survey

Stedman, Mike; Eltom, Saydah; Solomon, Emma; More

Cardiovascular Endocrinology & Metabolism. 11(2):e0262, June 2022.

Get Content & Permissions

Open

Cardiovascular Endocrinology & Metabolism is moving to Open Access

In response to funder mandates and Plan S, from January 2021, Cardiovascular Endocrinology & Metabolism will become a Gold Open Access journal. For more information, please visit the Information for Authors here.

We are very excited about this new initiative and we welcome you to submit your research and reviews for publication in the journal. Articles should be submitted online at www.editorialmanager.com/caen

Book your place now!

New webinar series from the Royal Society of Medicine on pharmacotherapy treatments for the prevention and treatment of cardiovascular disease.

Secondary Logo

Journal Logo

Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologists

Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities

Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ...

Featured Supplement (s)

Current Issue

Original article

Reducing fatigue-related symptoms in Long COVID-19: a preliminary report of a lymphatic drainage intervention

Naltrexone alters cardiovascular function following acute forced swimming in mice

Short report

A survey of physician experience and treatment satisfaction prescribing once-weekly semaglutide injections for patients with type 2 diabetes in Canada

Correspondence

Living with diabetes and its impact on mental health: results of an online survey

Featured Articles

Cardiovascular disease in type 1 diabetes: the elephant in the clinic

Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications study

The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it

Cardiovascular disease in type 1 diabetes

Type 1 diabetes mellitus and coronary revascularization

Vascular disease in the lower limb in type 1 diabetes

Current Issue Highlights

Original article

Reducing fatigue-related symptoms in Long COVID-19: a preliminary report of a lymphatic drainage intervention

Short report

A survey of physician experience and treatment satisfaction prescribing once-weekly semaglutide injections for patients with type 2 diabetes in Canada

Correspondence

Living with diabetes and its impact on mental health: results of an online survey

Journal Info

Cardiovascular Endocrinology & Metabolism is moving to Open Access

Book your place now!

Editor's Picks

RegPep 2016

Most Popular

Free Online Issue